Immunotherapy for Small Cell Lung Cancer in Mice
Author Information
Author(s): A. Smith, R. Waibel, R.A. Stahel
Primary Institution: University Hospital, Zurich, Switzerland
Hypothesis
Can the SWA II antibody effectively treat small cell lung cancer xenografts in a mouse model?
Conclusion
The study found that the SWA II antibody significantly reduced tumor growth in small cell lung cancer xenografts.
Supporting Evidence
- The SWA II antibody led to significant anti-tumor effects in both small and large xenografts.
- Xenografts treated with the antibody showed large areas of necrosis and very few residual cancer cells.
- Multiple injections of the antibody prevented tumor regrowth for the duration of the study.
Takeaway
Researchers tested a special antibody to see if it could help shrink tumors in mice with lung cancer, and it worked really well!
Methodology
The study used a nude mouse model to evaluate the effects of SWA II antibody on small cell lung cancer xenografts with both single and multiple injections.
Limitations
The results are based on a mouse model, which may not directly translate to human patients.
Participant Demographics
Female NMRI nu/nu mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website